Lumexa Imaging (LMRI.US) IPO is priced at $18.50 and plans to raise $463 million

The Zhitong Finance App learned that the US diagnostic imaging service provider Lumexa Imaging Holdings (LMRI.US) issued 25 million shares at a price of 18.50 US dollars per share, raised 463 million US dollars, and the price was within the distribution range of 17 to 20 US dollars. After listing, the company's market value will reach 1.8 billion US dollars, and the corporate value will be 2.6 billion US dollars.

Lumexa is a national provider of outpatient diagnostic imaging services in the US. Through wholly-owned sites and joint ventures with healthcare systems, Lumexa operates 184 imaging centers in 13 states. The company provides a range of advanced and conventional imaging equipment including magnetic resonance, CT, PET scans, X-rays, ultrasound and mammography. In the 12 months ending September 30, 2025, the company achieved sales of $1 billion.

Lumexa Imaging Holdings plans to list on the NASDAQ under the ticker “LMRI.” Joint bookkeepers for this offering include Barclays, J.P. Morgan Chase, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, and Raymond James.